Pharmacologic Treatments for PCOS Patients
| Autor: | Saioa Torrealday, Samantha Kodama |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Pediatrics medicine.medical_specialty 030219 obstetrics & reproductive medicine business.industry MEDLINE Obstetrics and Gynecology medicine.disease Androgen Excess Mental health Endometrial hyperplasia Anovulation 03 medical and health sciences 0302 clinical medicine Diabetes mellitus medicine Humans Female Dietary modifications business Infertility Female Life Style Menstruation Disturbances Dyslipidemia Polycystic Ovary Syndrome |
| Zdroj: | Clinical Obstetrics & Gynecology. 64:55-64 |
| ISSN: | 0009-9201 |
| DOI: | 10.1097/grf.0000000000000597 |
| Popis: | Polycystic ovarian syndrome is the most common endocrinopathy in reproductive-aged women and has a vast array of clinical manifestations. Common clinical presentations of the disorder include anovulatory infertility, menstrual disorders, cutaneous symptoms secondary to androgen excess, metabolic abnormalities and mental health issues. If the condition is left unaddressed or inadequately treated, long-term sequelae such as endometrial hyperplasia, diabetes mellitus and dyslipidemia may ensue, therefore it is imperative for clinicians to address each component of the syndrome. When initial lifestyle changes and dietary modifications do not suffice or fail, pharmacologic therapy should be considered, and when deemed appropriate treatment should be initiated. This review describes the pharmacologic options available to combat the various sequelae commonly seen in women with polycystic ovarian syndrome. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|